Christopher Benner

Dr. Christopher Benner

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2010 in Molecular Cell
Verified
Journal Article
Closed access
SHSven Heinz
Sven Heinz
CBChristopher Benner
Christopher Benner
NSNathanael Spann
Nathanael Spann
EBEric Bertolino
Eric Bertolino
YLYin C. Lin
Yin C. Lin
CGChristopher K. Glass
Christopher K. Glass

3 April 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
YZYingyao Zhou
Yingyao Zhou
BZBin Zhou
Bin Zhou
LPLars Pache
Lars Pache
MCMax Chang
Max Chang
AKAlireza Hadj Khodabakhshi
Alireza Hadj Khodabakhshi
SCSumit K. Chanda
Sumit K. Chanda
A critical component in the interpretation of systems-level studies is the inference of enriched biological pathways and protein complexes contained within OMICs datasets. Successful analysis requires the integration of a broad set of current biological databases and the application of a robust analytical pipeline to produce readily interpretable results. Metascape is a web-based portal designed to provide a comprehensive gene list annotation and analysis resource for experimental biologists. In terms of design features, Metascape combines functional enrichment, interactome analysis, gene annotation, and membership search to leverage over 40 independent knowledgebases within one integrated portal. Additionally, it facilitates comparative analyses of datasets across multiple independent and orthogonal experiments. Metascape provides a significantly simplified user experience through a one-click Express Analysis interface to generate interpretable outputs. Taken together, Metascape is an effective and efficient tool for experimental biologists to comprehensively analyze and interpret OMICs-based studies in the big data era.

4 February 2015 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
PDF file
SHSven Heinz
Sven Heinz
CRCasey E. Romanoski
Casey E. Romanoski
CBChristopher Benner
Christopher Benner
CGChristopher K. Glass
Christopher K. Glass

1 August 2013 in Molecular Cell
Verified
Journal Article
Closed access
MKMinna U Kaikkonen
Minna U Kaikkonen
NSNathanael J. Spann
Nathanael J. Spann
SHSven Heinz
Sven Heinz
CRCasey E. Romanoski
Casey E. Romanoski
KAKarmel A. Allison
Karmel A. Allison
CGChristopher K. Glass
Christopher K. Glass

8 November 2017 in Nature
Verified
Journal Article
Open access
PDF file
SSShabnam Shalapour
Shabnam Shalapour
XLXue-Jia Lin
Xue-Jia Lin
IBIngmar N. Bastian
Ingmar N. Bastian
JBJohn Brain
John Brain
ABAlastair D. Burt
Alastair D. Burt
MKMichael Karin
Michael Karin
IgA+ B cells expressing programmed death ligand 1 (PD-L1) and interleukin 10 accumulate in the inflamed livers of humans and mice with non-alcoholic fatty liver disease where they promote the progression to hepatocellular carcinoma by limiting the local activation of PD-1-expressing CD8+ T cells. The role of adaptive immunity in early cancer development is controversial. Here we show that chronic inflammation and fibrosis in humans and mice with non-alcoholic fatty liver disease is accompanied by accumulation of liver-resident immunoglobulin-A-producing (IgA+) cells. These cells also express programmed death ligand 1 (PD-L1) and interleukin-10, and directly suppress liver cytotoxic CD8+ T lymphocytes, which prevent emergence of hepatocellular carcinoma and express a limited repertoire of T-cell receptors against tumour-associated antigens. Whereas CD8+ T-cell ablation accelerates hepatocellular carcinoma, genetic or pharmacological interference with IgA+ cell generation attenuates liver carcinogenesis and induces cytotoxic T-lymphocyte-mediated regression of established hepatocellular carcinoma. These findings establish the importance of inflammation-induced suppression of cytotoxic CD8+ T-lymphocyte activation as a tumour-promoting mechanism. Cancer progression beyond the early stages is thought to be caused in some cases by adaptive immunity, but its role remains controversial. In this study, Michael Karin and colleagues show that PD-L1-expressing IgA+ B cells accumulate in the inflamed livers of humans and mice with non-alcoholic fatty liver disease. The inflammation-induced IgA+ cells promote the progression to hepatocellular carcinoma by suppressing liver cytotoxic CD8+ T cells that prevent the emergence of this aggressive tumour.

13 June 2010 in Nature Immunology
Verified
Journal Article
Open access
PDF file
YLYin C Lin
Yin C Lin
SJSuchit Jhunjhunwala
Suchit Jhunjhunwala
CBChristopher Benner
Christopher Benner
SHSven Heinz
Sven Heinz
EWEva Welinder
Eva Welinder
CMCornelis Murre
Cornelis Murre
Lineage specification and development require a hierarchy of transcription factors. Murre and colleagues have compiled a genome-wide set of cis-acting targets centered on E2A, EBF1 and Foxo1 that govern early B cell development. It is now established that the transcription factors E2A, EBF1 and Foxo1 have critical roles in B cell development. Here we show that E2A and EBF1 bound regulatory elements present in the Foxo1 locus. E2A and EBF1, as well as E2A and Foxo1, in turn, were wired together by a vast spectrum of cis-regulatory sequences. These associations were dynamic during developmental progression. Occupancy by the E2A isoform E47 directly resulted in greater abundance, as well as a pattern of monomethylation of histone H3 at lysine 4 (H3K4) across putative enhancer regions. Finally, we divided the pro-B cell epigenome into clusters of loci with occupancy by E2A, EBF and Foxo1. From this analysis we constructed a global network consisting of transcriptional regulators, signaling and survival factors that we propose orchestrates B cell fate.